1. Home
  2. OVID vs TLRY Comparison

OVID vs TLRY Comparison

Compare OVID & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OVID

Ovid Therapeutics Inc.

N/A

Current Price

$2.56

Market Cap

503.9M

Sector

Health Care

ML Signal

N/A

Logo Tilray Brands Inc.

TLRY

Tilray Brands Inc.

N/A

Current Price

$2.49

Market Cap

533.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OVID
TLRY
Founded
2014
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
503.9M
533.5M
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
OVID
TLRY
Price
$2.56
$2.49
Analyst Decision
Strong Buy
Buy
Analyst Count
13
10
Target Price
★ $6.40
$5.72
AVG Volume (30 Days)
2.4M
★ 4.2M
Earning Date
11-10-2026
10-08-2026
Dividend Yield
N/A
N/A
EPS Growth
3.90
★ 55.69
EPS
★ N/A
N/A
Revenue
★ $7,252,000.00
N/A
Revenue This Year
N/A
$20.44
Revenue Next Year
N/A
$5.29
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 1181.27
N/A
52 Week Low
$1.18
$0.77
52 Week High
$3.11
$15.70

Technical Indicators

Market Signals
Indicator
OVID
TLRY
Relative Strength Index (RSI) 50.37 32.01
Support Level $2.12 $2.49
Resistance Level $2.67 $3.00
Average True Range (ATR) 0.24 0.15
MACD 0.03 0.03
Stochastic Oscillator 44.95 4.76

Price Performance

Historical Comparison
OVID
TLRY

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About TLRY Tilray Brands Inc.

Tilray is as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. The company portfolio includes brand such as Sweet Water Brewing, Montauk Brewing, Brew Dog, Shock Top, 10 Barrell, Breckenridge Brewery, Blue Point Brewing, Breckenridge Distillery, Revolver, Terrapin, Broken Coast, Good Supply, Redecan, Solei, Tilray, ARX, XMG, Manitoba Harvest and Hi-Ball. The company has four segment Beverage, Cannabis, Distribution and Wellness. The majority of the revenue is generated from Distribution business which encompasses the purchase and resale of pharmaceuticals products to customers.

Share on Social Networks: